The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece

Gout is an autoinflammatory disease caused by monosodium urate mono hydrate crystal deposition in tissues or the supersaturation of extracellular fluids of uric acid. In this study, we are going to report the experience of the Asklepeion Voula Rheumatology Clinic, treating four patients with gouty a...

Descripción completa

Detalles Bibliográficos
Autores principales: Theotikos, Evangelos, Raftakis, Ioannis, Elezoglou, Antonia, Antoniadis, Christodoulos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2017
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045930/
https://www.ncbi.nlm.nih.gov/pubmed/32185254
http://dx.doi.org/10.31138/mjr.28.1.48
_version_ 1783501872603070464
author Theotikos, Evangelos
Raftakis, Ioannis
Elezoglou, Antonia
Antoniadis, Christodoulos
author_facet Theotikos, Evangelos
Raftakis, Ioannis
Elezoglou, Antonia
Antoniadis, Christodoulos
author_sort Theotikos, Evangelos
collection PubMed
description Gout is an autoinflammatory disease caused by monosodium urate mono hydrate crystal deposition in tissues or the supersaturation of extracellular fluids of uric acid. In this study, we are going to report the experience of the Asklepeion Voula Rheumatology Clinic, treating four patients with gouty arthritis who received Canakinumab.
format Online
Article
Text
id pubmed-7045930
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Mediterranean Journal of Rheumatology (MJR)
record_format MEDLINE/PubMed
spelling pubmed-70459302020-03-17 The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece Theotikos, Evangelos Raftakis, Ioannis Elezoglou, Antonia Antoniadis, Christodoulos Mediterr J Rheumatol Case Series Gout is an autoinflammatory disease caused by monosodium urate mono hydrate crystal deposition in tissues or the supersaturation of extracellular fluids of uric acid. In this study, we are going to report the experience of the Asklepeion Voula Rheumatology Clinic, treating four patients with gouty arthritis who received Canakinumab. The Mediterranean Journal of Rheumatology (MJR) 2017-03-28 /pmc/articles/PMC7045930/ /pubmed/32185254 http://dx.doi.org/10.31138/mjr.28.1.48 Text en © 2017 The Mediterranean Journal of Rheumatology (MJR) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
spellingShingle Case Series
Theotikos, Evangelos
Raftakis, Ioannis
Elezoglou, Antonia
Antoniadis, Christodoulos
The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece
title The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece
title_full The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece
title_fullStr The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece
title_full_unstemmed The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece
title_short The use of Canakinumab in treating resistant gouty disease in patients with limited therapeutic options: The experience of the Rheumatology Clinic of Asklipeion General Hospital of Voula, Greece
title_sort use of canakinumab in treating resistant gouty disease in patients with limited therapeutic options: the experience of the rheumatology clinic of asklipeion general hospital of voula, greece
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045930/
https://www.ncbi.nlm.nih.gov/pubmed/32185254
http://dx.doi.org/10.31138/mjr.28.1.48
work_keys_str_mv AT theotikosevangelos theuseofcanakinumabintreatingresistantgoutydiseaseinpatientswithlimitedtherapeuticoptionstheexperienceoftherheumatologyclinicofasklipeiongeneralhospitalofvoulagreece
AT raftakisioannis theuseofcanakinumabintreatingresistantgoutydiseaseinpatientswithlimitedtherapeuticoptionstheexperienceoftherheumatologyclinicofasklipeiongeneralhospitalofvoulagreece
AT elezoglouantonia theuseofcanakinumabintreatingresistantgoutydiseaseinpatientswithlimitedtherapeuticoptionstheexperienceoftherheumatologyclinicofasklipeiongeneralhospitalofvoulagreece
AT antoniadischristodoulos theuseofcanakinumabintreatingresistantgoutydiseaseinpatientswithlimitedtherapeuticoptionstheexperienceoftherheumatologyclinicofasklipeiongeneralhospitalofvoulagreece
AT theotikosevangelos useofcanakinumabintreatingresistantgoutydiseaseinpatientswithlimitedtherapeuticoptionstheexperienceoftherheumatologyclinicofasklipeiongeneralhospitalofvoulagreece
AT raftakisioannis useofcanakinumabintreatingresistantgoutydiseaseinpatientswithlimitedtherapeuticoptionstheexperienceoftherheumatologyclinicofasklipeiongeneralhospitalofvoulagreece
AT elezoglouantonia useofcanakinumabintreatingresistantgoutydiseaseinpatientswithlimitedtherapeuticoptionstheexperienceoftherheumatologyclinicofasklipeiongeneralhospitalofvoulagreece
AT antoniadischristodoulos useofcanakinumabintreatingresistantgoutydiseaseinpatientswithlimitedtherapeuticoptionstheexperienceoftherheumatologyclinicofasklipeiongeneralhospitalofvoulagreece

Ejemplares similares